Quick Answer
HeartSciences Inc. reported Stockholders Equity of $205.2 thousand for fiscal year 2025.
HeartSciences Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $205.2K | -97.2% |
| 2024 | $7.32M | +3073.7% |
| 2023 | $230.6K | +103.8% |
| 2022 | -$6.06M | -217.1% |
| 2021 | -$1.91M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| January 31, 2026 | $2.65M | +48.4% | -36.6% |
| October 31, 2025 | $4.18M | +4.1% | +33.2% |
| July 31, 2025 | $3.14M | -47.1% | +1431.0% |
| April 30, 2025 | $205.2K | -97.2% | -88.5% |
| January 31, 2025 | $1.79M | -79.3% | -55.5% |
| October 31, 2024 | $4.02M | +343.5% | -32.3% |
| July 31, 2024 | $5.93M | +1241.8% | -18.9% |
| April 30, 2024 | $7.32M | +3073.7% | -15.2% |
- HeartSciences Inc. showed a decrease of -97.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2021–2025 period, HeartSciences Inc.’s stockholders equity has grown by 110.7% (from -$1.91 million to $205.2 thousand).
- The most recent figure is from HeartSciences Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: